Page last updated: 2024-08-26

fulvestrant and batimastat

fulvestrant has been researched along with batimastat in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kirkegaard, T; Kveiborg, M; Lykkesfeldt, AE; Yde, CW	1

Other Studies

1 other study(ies) available for fulvestrant and batimastat

Article	Year
The broad-spectrum metalloproteinase inhibitor BB-94 inhibits growth, HER3 and Erk activation in fulvestrant-resistant breast cancer cell lines. International journal of oncology, 2014, Volume: 45, Issue:1 Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Proliferation; Drug Resistance, Neoplasm; ErbB Receptors; Estradiol; Extracellular Signal-Regulated MAP Kinases; Female; Fulvestrant; Humans; MCF-7 Cells; Phenylalanine; Phosphorylation; Protease Inhibitors; Receptor, ErbB-3; Thiophenes	2014

Article

Year

The broad-spectrum metalloproteinase inhibitor BB-94 inhibits growth, HER3 and Erk activation in fulvestrant-resistant breast cancer cell lines.

International journal of oncology, 2014, Volume: 45, Issue:1

Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Proliferation; Drug Resistance, Neoplasm; ErbB Receptors; Estradiol; Extracellular Signal-Regulated MAP Kinases; Female; Fulvestrant; Humans; MCF-7 Cells; Phenylalanine; Phosphorylation; Protease Inhibitors; Receptor, ErbB-3; Thiophenes

2014